Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
- Check20 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check27 days agoChange DetectedThe page has removed specific information regarding the modernization of ClinicalTrials.gov data ingest expected in July 2025, along with the previous version details and a date reference for July 2024.SummaryDifference5%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check56 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.